Classification of preinvasive breast and carcinoma in situ: Doubts, controversies, and proposal for new categorizations;Classification des lésions pré-invasives et des carcinomes in situ: Doutes, controverses, proposition de nouvelles classifications

Bulletin du Cancer

Volumn 91, Issue SPEC. ISS. DEC., 2004, Pages

  Dauplat, Marie Mélanie ^a   Penault Llorca, Frédérique ^a  

^a CENTRE JEAN PERRIN   (France)

Author keywords

Atypical ductal hyperplasia; Comparative genomic hybridisation; Ductal carcinoma in situ; Flat epithelial atypia; Lobular neoplasia; Loss of heterozygosity; Usual ductal hyperplasia

Indexed keywords

BREAST CARCINOMA; BREAST DUCT; CALCIFICATION; CANCER CLASSIFICATION; CANCER SCREENING; CARCINOMA IN SITU; CELL STRUCTURE; COMPARATIVE GENOMIC HYBRIDIZATION; DUCTAL CARCINOMA IN SITU; EPITHELIUM HYPERPLASIA; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; MAMMOGRAPHY; PHENOTYPE; REVIEW;

BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; HYPERPLASIA; METAPLASIA; PRECANCEROUS CONDITIONS;

EID: 12244284020     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Arnould L, Caron Y, Sigal-Zafrani B. La prise en charge des carcinomes canalaires in situ par les pathologistes: questions d'actualité. Ann Pathol 2003; 23: 534-46.
2. Pinder SE, Ellis IO. The diagnosis and management of pre-invasive breast disease ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)-current definitions and classification. Breast Cancer Res 2003; 5: 254-7.
3. Tavassoli FA. Ductal intraepithelial neoplasia of the breast. Virchows Arch 2001; 438: 221-7.
4. Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease. Genetic alterations in pre-invasive lesions. Breast Cancer Res 2003; 5: 313-9.
5. Badve S. The diagnosis and management of pre-invasive breast disease: another point of view. Breast Cancer Res 2004; 6: E3.
6. Tavassoli FA, Hoefler H, Rosai J, Holland R, Ellis IO, Schnitt SJ, et al. Intraductal proliferative lesions. In: Tavassoli FA, Devilee P, eds. Tumors of the breast and female genital organs. World Health Organization Classification of tumours. Lyon: IARC Press, 2003.
7. Lakhani S, Slack D, Hamoudi R, Collins N, Stratton M, Sloane J. Detection of alleleic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest 1996; 74: 129-35.
8. Gong G, DeVries S, Chew KL, Cha I, Ljung BM, Waldman FM. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization. Clin Cancer Res 2001; 7: 2410-4.
9. Jones C, Merrett S, Thomas VA, Barker TH, Lakhani SR. Comparative genomic hybridization analysis of bilateral hyperplasia of usual type of the breast. J Pathol 2003; 199: 152-6.
10. Sorlie T, Tibshirani R, Parker J, Hastic T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 2003; 100: 8418-23.
11. Schnitt SJ. Flat epithelial atypia-classification, pathologic features and clinical significance. Breast Cancer Res 2003; 5: 263-8.
12. Vincent-Salomon A. La métaplasie cylindrique: un diagnostic fréquent en pathologie mammaire! Ann Pathol 2003; 23: 593-6.
13. Bratthauer GL, Tavassoli FA. Assessment of lesions coexisting with various grades of ductal intraepithelial neoplasia of the breast. Virchows Arch 2004; 444: 340-4.
14. Kim HJ, Jung WH, Kim DY, Lee HD. Expression of cyclins in ductal hyperplasia, atypical ductal hyperplasia and ductal carcinoma in situ of the breast. Yonsei Med J 2000; 41: 345-53.
15. Faverly DR, Burgers L, Bult P, Holland R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994; 11: 193-8.
16. Van de Vijver M, Peterse H. The diagnosis and management of preinvasive breast disease. Pathological diagnosis - problems with existing classifications. Breast Cancer Res 2003; 5: 269-75.
17. Ellis IO, Pinder SE, Elston CW. A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going? Semin Diagn Pathol 1999; 16: 202-8.
18. Schnitt SJ, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol 1999; 16: 209-23.
19. Lakhani SR. In situ lobular neoplasia: time for awakening. Lancet 2003; 361: 96.
20. Simpson PT, Gale T, Fulfor LG, Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease. Pachology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 2003; 5: 258-62.
21. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Simpson JF. Atypical lobulat hyperplasia as a unilateral predictot of breast cancer risk: a retrospective cohort study. Lancet 2003; 361: 125-9.
22. Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 1997; 6: 297-301.
23. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985; 312: 146-51.
24. Tavassoli FA, Millis RR, Boecker W, Lakhani SR. Lobular neoplasia. In: Tavassoli FA, Devilee P, eds. Tumors of the breast and female genital organs. World Health Organization Classification of tumours. Lyon: IARC press, 2003: 60-4.
25. Shelley Hwang E, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004; 100: 2562-72.
26. Sigal-Zafrani B, Vincent-Salomon A, Penault-Llorca F, Sastre-Garau X. Neoplasies lobulaires. Ann Pathol 2003; 23: 547-643.
27. Tavassoli FA. Pathology of the breast. Stanford, Connecticut: Appleton Lange, 1999.